Conclusion
DCIS is rare in men and the lack of standardized diagnostic procedures
and evidence-based treatment guidelines may contribute to poorer
outcomes compared to women. The research is limited, and a lack of
randomized control trials cannot inform standard of care. The management
and the overall outcome of male breast cancer can be improved through
early detection screening, genetic counseling, and high-quality
treatment.3 These changes may help to guide
challenging decisions and cases of male breast cancer.